A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS
The original article tells about the key aspects that characterize the problem of acute coronary syndrome without ST-segment elevation (ACSWSTE) in the Russian Federation: high prevalence, current approaches to risk assessment of early and long-term adverse outcomes and diagnostic challenges. Based...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2017-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1766 |
| _version_ | 1827962386104975360 |
|---|---|
| author | O. L. Barbarash V. V. Kashtalap |
| author_facet | O. L. Barbarash V. V. Kashtalap |
| author_sort | O. L. Barbarash |
| collection | DOAJ |
| description | The original article tells about the key aspects that characterize the problem of acute coronary syndrome without ST-segment elevation (ACSWSTE) in the Russian Federation: high prevalence, current approaches to risk assessment of early and long-term adverse outcomes and diagnostic challenges. Based on the data from the All-Russian Register RECORD-3, the main factors limiting the effectiveness of treatment of patients with ACSWSTE are highlighted: underestimated relevance of risk calculators (GRACE) and biological markers for myocardial necrosis by practicing physicians who manage these patients, underutilization of invasive treatment, failure to prescribe drugs that improve prognosis, including dual antiplatelet therapy in patients with conservative management. The prospects for the use of ticagrelor (Brilinta) to improve short- and long-term prognosis of the disease are estimated. |
| first_indexed | 2024-04-09T16:41:48Z |
| format | Article |
| id | doaj.art-e63db0f2815b4a0ebbc11ff85ecbeb47 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:41:48Z |
| publishDate | 2017-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-e63db0f2815b4a0ebbc11ff85ecbeb472023-04-23T06:56:39ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902017-12-0107283810.21518/2079-701X-2017-7-28-381748A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSISO. L. Barbarash0V. V. Kashtalap1Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo State Medical University, MoH RFResearch Institute for Complex Issues of Cardiovascular Diseases, Kemerovo State Medical University, MoH RFThe original article tells about the key aspects that characterize the problem of acute coronary syndrome without ST-segment elevation (ACSWSTE) in the Russian Federation: high prevalence, current approaches to risk assessment of early and long-term adverse outcomes and diagnostic challenges. Based on the data from the All-Russian Register RECORD-3, the main factors limiting the effectiveness of treatment of patients with ACSWSTE are highlighted: underestimated relevance of risk calculators (GRACE) and biological markers for myocardial necrosis by practicing physicians who manage these patients, underutilization of invasive treatment, failure to prescribe drugs that improve prognosis, including dual antiplatelet therapy in patients with conservative management. The prospects for the use of ticagrelor (Brilinta) to improve short- and long-term prognosis of the disease are estimated.https://www.med-sovet.pro/jour/article/view/1766acute coronary syndrome without st-segment elevationrisk assessmentinvasive treatmentdual antiplatelet therapyticagrelor (brilinta) |
| spellingShingle | O. L. Barbarash V. V. Kashtalap A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS Медицинский совет acute coronary syndrome without st-segment elevation risk assessment invasive treatment dual antiplatelet therapy ticagrelor (brilinta) |
| title | A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS |
| title_full | A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS |
| title_fullStr | A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS |
| title_full_unstemmed | A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS |
| title_short | A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION AND CONSERVATIVE MANAGEMENT. PHARMACOLOGICAL OPTIONS TO IMPROVE PROGNOSIS |
| title_sort | patient with acute coronary syndrome without st segment elevation and conservative management pharmacological options to improve prognosis |
| topic | acute coronary syndrome without st-segment elevation risk assessment invasive treatment dual antiplatelet therapy ticagrelor (brilinta) |
| url | https://www.med-sovet.pro/jour/article/view/1766 |
| work_keys_str_mv | AT olbarbarash apatientwithacutecoronarysyndromewithoutstsegmentelevationandconservativemanagementpharmacologicaloptionstoimproveprognosis AT vvkashtalap apatientwithacutecoronarysyndromewithoutstsegmentelevationandconservativemanagementpharmacologicaloptionstoimproveprognosis AT olbarbarash patientwithacutecoronarysyndromewithoutstsegmentelevationandconservativemanagementpharmacologicaloptionstoimproveprognosis AT vvkashtalap patientwithacutecoronarysyndromewithoutstsegmentelevationandconservativemanagementpharmacologicaloptionstoimproveprognosis |